Shopping Cart (0)
My Account

Your Shopping Cart
Point-of-Care Diagnostics World CongressExosomes & Single Cell Analysis SummitLab-on-a-Chip, Microfluidics & Microarray World CongressAcademic Discovery WorkshopAdvances in Plant Genomics - Online Event20% Discount OfferePoster Award PrizeBlogs

MicroRNAs and Exosomes Market Report 2012

Publisher: Select Biosciences
Published: August 2012
Pages: 168

Price:



Disease Associations and Circulating Biomarkers


GEN Article

This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomes markets as they are evolving.  In this report, we focus upon the microRNA research marketplace from the perspective of the translational opportunities in these spaces.  The focus of this field is moving from basic research towards the utility of associations of microRNA expression patterns in disease.  In this manner, microRNA signatures may be validated as biomarkers in many disease areas—cancers, cardiovascular disease, neurological disease, inflammation, and metabolic diseases.

  • Select Biosciences has performed worldwide market tracking wherein we’ve analyzed end-user research trends in the microRNA as well as Exosome markets—these areas are evolving in parallel given the opportunity in the Circulating Biomarkers space and the utility of microRNAs and mRNAs to be harvested from exosomes and assayed as signatures for disease.
  • For exosomes, we’ve analyzed the research trends, types of downstream applications being performed as well as biomarker classes being studied currently and this is the First Market Report to Document the Market Landscape of Exosomes.

Select Biosciences has characterized the associations of microRNAs in various disease classes and presents these detailed associations as “hotspot maps” in this report.  Specifically, these associations [to be interpreted as starting material for biomarker development and validation] are described for many cancer classes, cardiovascular disease, CNS disease, diabetes, inflammation, and obesity.  They offer the opportunity for R&D planning efforts addressing the question of “which microRNA content needs to be addressed in a particular disease class.”

This data-driven characterization of the microRNAs and Exosomes landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans—this Market Report is written and delivered to customers in PowerPoint format.

Extensive Technical and Market Analyses
Presented in this Report

  • MicroRNA Research Market Analysis
    • Research Market Size and Growth Rate
    • Grant Funding Metrics
    • Qualitative and Quantitative Research Market Trends
      • Segmentation of Research Activities
      • Market Penetrance of Product Vendors into the microRNA Research Market
      • Unmet Needs
  • Association of microRNA Expression Patterns in Various Disease Classes
    • Various Types of Cancer: Breast Cancer, Lung Cancer, Prostate Cancer, Pancreatic Cancer, GI Tract Cancers, Hematological Malignancies
    • Muscular Development and Cardiovascular Disease
    • CNS Disease
    • Metabolic Disease, Diabetes
    • Stem Cells
    • Liver Disease, Liver Toxicity
  • Exosomes Marketplace
    • Nature and Categorization
    • Current Research Trends based on Primary Market Survey
    • Downstream Applications
  • Circulating Biomarkers
    • Utility of microRNA Signatures
    • microRNA Signatures in Specific Cancers Characterized in Biological Fluids to Date

Report Table of Contents (TOC) [Click Here to Download PDF File]


For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News
Submission Deadline Extended to the 15 August 2014
Submission Deadline Extended to the 15 August 2014
Submit your abstract for consideration to present at Lab-on-a-Chip Asia - Microfluidics and Point-of-Care Diagnostics.


Accreditation
“The Medical Association of Saxony certificates the two-day congress with 16 continuing education points.”


SONY DADC PreConference Workshop, September 17, 2014 from 16:30-18:30
SONY DADC PreConference Workshop, September 17, 2014 from 16:30-18:30
Defining Commercialization Roadmaps for Emerging Technologies into Smart Consumables for in-vitro Diagnostics. Free Admission to this PreConference Workshop.


Keynote Speaker Confirmed, Stephen Minger
We are thrilled to announce that Stephen Minger, Global Director of GE Healthcare, has confirmed he will be giving a keynote presentation at Stem Cells in Drug Discovery 2015.


Site Visit to the SIMTech Microfluidics Foundry
Site Visit to the SIMTech Microfluidics Foundry
Take advantage of a tour of the facilities at the SIMTech Microfluidic Foundry. Dr. Zhiping Wang, Director of Research Programmes, will be your host, providing all attendees with a detailed insight into the advanced work carried out by SIMTech. Don't miss out - Register today!


LAB-ON-A-CHIP ASIA - EARLY BIRD
SAVE UP TO S$ 255 - EARLY BIRD DEADLINE 10 OCTOBER 2014!

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com